Baillie Gifford & Co. lessened its holdings in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 14.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 835,488 shares of the company's stock after selling 139,307 shares during the quarter. Baillie Gifford & Co. owned 1.13% of Schrodinger worth $14,939,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in SDGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Schrodinger by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,055 shares of the company's stock worth $653,000 after purchasing an additional 1,412 shares in the last quarter. Cetera Investment Advisers lifted its position in shares of Schrodinger by 75.2% in the second quarter. Cetera Investment Advisers now owns 29,973 shares of the company's stock worth $603,000 after purchasing an additional 12,868 shares in the last quarter. Norges Bank bought a new stake in shares of Schrodinger in the second quarter worth $311,000. Invesco Ltd. lifted its position in shares of Schrodinger by 15.6% in the second quarter. Invesco Ltd. now owns 155,895 shares of the company's stock worth $3,137,000 after purchasing an additional 21,039 shares in the last quarter. Finally, First Trust Advisors LP bought a new stake in Schrodinger during the second quarter worth $1,227,000. Institutional investors own 79.05% of the company's stock.
Schrodinger Price Performance
NASDAQ:SDGR opened at $11.45 on Tuesday. Schrodinger, Inc. has a one year low of $10.94 and a one year high of $27.63. The company has a market cap of $845.24 million, a P/E ratio of -8.06 and a beta of 1.62. The firm's fifty day moving average price is $12.07 and its two-hundred day moving average price is $16.21.
Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of ($0.13) by $0.57. Schrodinger had a negative net margin of 40.37% and a negative return on equity of 29.47%. The firm had revenue of $87.24 million for the quarter, compared to the consensus estimate of $83.66 million. During the same period in the previous year, the company earned ($0.24) earnings per share. The company's quarterly revenue was up 4.7% on a year-over-year basis. As a group, equities research analysts expect that Schrodinger, Inc. will post -2.37 earnings per share for the current year.
Insider Activity at Schrodinger
In other Schrodinger news, CEO Ramy Farid sold 3,661 shares of the company's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $12.91, for a total value of $47,263.51. Following the transaction, the chief executive officer directly owned 330,824 shares in the company, valued at $4,270,937.84. The trade was a 1.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 15,340 shares of company stock valued at $200,605 in the last 90 days. 21.00% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research firms have issued reports on SDGR. Bank of America raised shares of Schrodinger from a "neutral" rating to a "buy" rating and set a $24.00 price target on the stock in a research report on Monday, December 15th. UBS Group dropped their price target on shares of Schrodinger from $18.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 17th. KeyCorp dropped their price target on shares of Schrodinger from $25.00 to $20.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. TD Cowen reaffirmed a "buy" rating on shares of Schrodinger in a research report on Thursday, January 8th. Finally, Wall Street Zen raised shares of Schrodinger from a "sell" rating to a "hold" rating in a research report on Saturday, January 31st. Four analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $20.50.
Check Out Our Latest Report on SDGR
Schrodinger Company Profile
(
Free Report)
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
See Also
Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrodinger, Inc. (NASDAQ:SDGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.